2021 Q4 Form 10-Q Financial Statement

#000149315221028692 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $24.12K $8.500K
YoY Change
Cost Of Revenue $5.030K
YoY Change
Gross Profit $19.09K
YoY Change
Gross Profit Margin 79.15%
Selling, General & Admin $1.509M $2.025M $280.1K
YoY Change -17.35% 623.24% 16.69%
% of Gross Profit 7907.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.150K $1.310K $0.00
YoY Change 325.93%
% of Gross Profit 6.02%
Operating Expenses $1.489M $2.567M $280.1K
YoY Change -16.63% 816.57% 16.69%
Operating Profit -$1.470M -$2.567M
YoY Change
Interest Expense -$46.27K -$201.8K -$45.75K
YoY Change 24.08% 341.01% 357.5%
% of Operating Profit
Other Income/Expense, Net -$201.8K
YoY Change
Pretax Income -$1.516M -$2.769M -$317.3K
YoY Change -16.85% 772.55% 26.92%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.516M -$2.769M -$317.3K
YoY Change -16.85% 772.55% 26.92%
Net Earnings / Revenue -6287.15% -3732.94%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$6.408K -$11.77K -$1.545K
COMMON SHARES
Basic Shares Outstanding 246.7M shares 235.2M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $522.1K $490.1K $44.47K
YoY Change 1459.56% 1002.05% -75.36%
Cash & Equivalents $359.1K $295.1K $1.470K
Short-Term Investments $163.0K $195.0K $43.00K
Other Short-Term Assets $0.00 $0.00
YoY Change -100.0%
Inventory $290.7K
Prepaid Expenses
Receivables $78.72K
Other Receivables $0.00
Total Short-Term Assets $891.6K $490.1K $44.47K
YoY Change 248.75% 1002.05% -75.35%
LONG-TERM ASSETS
Property, Plant & Equipment $112.6K $2.140K
YoY Change 3717.05%
Goodwill $6.444M
YoY Change
Intangibles $3.333K
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.583M
YoY Change
Total Long-Term Assets $7.529M $73.95K $0.00
YoY Change 255986.53% -100.0%
TOTAL ASSETS
Total Short-Term Assets $891.6K $490.1K $44.47K
Total Long-Term Assets $7.529M $73.95K $0.00
Total Assets $8.421M $564.0K $44.47K
YoY Change 3156.32% 1168.34% -80.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.381M $1.210M $739.9K
YoY Change 122.75% 63.53% -76.46%
Accrued Expenses $662.2K $376.0K $1.281M
YoY Change 85.12% -70.65% 102.75%
Deferred Revenue
YoY Change
Short-Term Debt $1.793M $1.071M $871.1K
YoY Change 105.85% 22.96% 53.2%
Long-Term Debt Due $2.990K $0.00
YoY Change -96.0%
Total Short-Term Liabilities $3.839M $3.231M $2.997M
YoY Change 88.87% 7.8% -52.15%
LONG-TERM LIABILITIES
Long-Term Debt $147.0K $0.00 $3.540M
YoY Change -100.0%
Other Long-Term Liabilities $559.6K
YoY Change
Total Long-Term Liabilities $706.6K $0.00 $3.540M
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.839M $3.231M $2.997M
Total Long-Term Liabilities $706.6K $0.00 $3.540M
Total Liabilities $4.546M $3.231M $6.538M
YoY Change 123.63% -50.58% 4.38%
SHAREHOLDERS EQUITY
Retained Earnings -$234.2M
YoY Change
Common Stock $255.8K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.875M -$2.667M -$6.493M
YoY Change
Total Liabilities & Shareholders Equity $8.421M $564.0K $44.47K
YoY Change 3156.32% 1168.34% -80.86%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$1.516M -$2.769M -$317.3K
YoY Change -16.85% 772.55% 26.92%
Depreciation, Depletion And Amortization $1.150K $1.310K $0.00
YoY Change 325.93%
Cash From Operating Activities -$431.5K -$68.12K -$15.07K
YoY Change 531.68% 352.02% -384.34%
INVESTING ACTIVITIES
Capital Expenditures $10.00 $0.00
YoY Change -100.31%
Acquisitions
YoY Change
Other Investing Activities $239.0K $140.00
YoY Change
Cash From Investing Activities $239.0K $0.00 $140.00
YoY Change -7544.86% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 256.6K 328.4K 15.04K
YoY Change 253.77% 2083.78% -321.18%
NET CHANGE
Cash From Operating Activities -431.5K -68.12K -15.07K
Cash From Investing Activities 239.0K 0.000 140.0
Cash From Financing Activities 256.6K 328.4K 15.04K
Net Change In Cash 64.07K 260.3K 110.0
YoY Change 6243.56% 236554.55% -107.33%
FREE CASH FLOW
Cash From Operating Activities -$431.5K -$68.12K -$15.07K
Capital Expenditures $10.00 $0.00
Free Cash Flow -$431.5K -$68.12K
YoY Change 562.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
246722140 shares
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
USD
CY2020Q4 GTII Fine Art
FineArt
USD
CY2020Q4 us-gaap Other Assets
OtherAssets
USD
CY2021Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
USD
CY2020Q4 GTII Notes Payable Curren
NotesPayableCurren
USD
CY2020Q4 GTII Stock Deposits
StockDeposits
USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
USD
CY2020Q3 us-gaap Depreciation
Depreciation
USD
us-gaap Depreciation
Depreciation
USD
CY2020Q3 GTII Charitable Donations
CharitableDonations
USD
GTII Charitable Donations
CharitableDonations
USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
USD
CY2021Q2 GTII Stock Issued During Period Value Warrants Issued To Shareholders
StockIssuedDuringPeriodValueWarrantsIssuedToShareholders
USD
CY2021Q2 GTII Stock Issued During The Period For Escrow Potential Acquistion Of Bronx Family Eye And My Retina
StockIssuedDuringThePeriodForEscrowPotentialAcquistionOfBronxFamilyEyeAndMyRetina
USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
USD
GTII Increase Decrease In Interest Payablerelated Parties
IncreaseDecreaseInInterestPayablerelatedParties
USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
USD
GTII Cash Paid For Other Assets
CashPaidForOtherAssets
USD
GTII Cash Paid For Fixed Assets
CashPaidForFixedAssets
USD
GTII Cash Received From Debt Financing
CashReceivedFromDebtFinancing
USD
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
USD
us-gaap Interest Paid Net
InterestPaidNet
USD
us-gaap Interest Paid Net
InterestPaidNet
USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
GTII Stock Issued And Held In Escrow For Potential Acquisitions
StockIssuedAndHeldInEscrowForPotentialAcquisitions
USD
GTII Reclassification Of Notes Payable To Stock Deposits
ReclassificationOfNotesPayableToStockDeposits
USD
us-gaap Depreciation
Depreciation
USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2020 GTII Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
P0Y
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
USD
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2020 GTII Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Intrinsic Value Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIntrinsicValueGrantsInPeriod
USD
CY2020 GTII Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised
shares
CY2020 GTII Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue
shares
CY2020 GTII Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedIntrinsicValue
USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2020 GTII Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValueForfeited
USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
USD
GTII Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised
shares
GTII Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue
shares
GTII Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedIntrinsicValue
USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
GTII Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Intrinsic Value Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresIntrinsicValueForfeited
USD

Files In Submission

Name View Source Status
0001493152-21-028692-index-headers.html Edgar Link pending
0001493152-21-028692-index.html Edgar Link pending
0001493152-21-028692.txt Edgar Link pending
0001493152-21-028692-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
gtii-20210930.xsd Edgar Link pending
gtii-20210930_cal.xml Edgar Link unprocessable
gtii-20210930_def.xml Edgar Link unprocessable
gtii-20210930_lab.xml Edgar Link unprocessable
gtii-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending